Loading organizations...
Loading organizations...
Provider of cellular diagnosis, research, and treatment services.
Shanghai Cell Therapy Group has raised $210.8M across 2 funding rounds.
Shanghai Cell Therapy Group has raised $210.8M in total across 2 funding rounds.
Shanghai Cell Therapy Group has raised $210.8M in total across 2 funding rounds.
Shanghai Cell Therapy Group's investors include CCB International, Haier Capital, Jiuzhou Venture, China Industrial Asset Management, Anting People's Government, Legend Capital, Ningbo Yuanhui.
Shanghai Cell Therapy Group has raised $210.8M across 2 funding rounds. Most recently, it raised $76.7M Series D in March 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 24, 2021 | $76.7M Series D | CCB International, Haier Capital, Jiuzhou Venture | |
| Dec 17, 2018 | $134.1M Series C | China Industrial Asset Management, Haier Capital | Anting People's Government, Legend Capital, Ningbo Yuanhui |